Recent studies identified biomarkers and risk associated with retinal disorders in patients with DM, including C1q/TNF-related protein (CTRP3), lipasin, and microRNA-211, and these molecules may be novel therapeutic targets for the prevention or treatment of DR [15–18]. This evidence concerns the gene C1QTNF3 and retinal disorder.